These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 16632459

  • 21. Improved outcome of cytomegalovirus retinitis in AIDS patients after introduction of protease inhibitors.
    Casado JL, Perez-Elías MJ, Martí-Belda P, Antela A, Suarez M, Ciancas E, Frutos B, Perez MD, Guerrero A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct 01; 19(2):130-4. PubMed ID: 9768621
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun 01; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D.
    AIDS; 2000 May 26; 14(8):1041-9. PubMed ID: 10853987
    [Abstract] [Full Text] [Related]

  • 26. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ, Meenken C, Danner SA, Reiss P, de Smet MD.
    Br J Ophthalmol; 1998 Sep 26; 82(9):988-90. PubMed ID: 9893585
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2004 Dec 26; 111(12):2224-31. PubMed ID: 15582078
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease.
    Verbraak FD, Boom R, Wertheim-van Dillen PM, van den Horn GJ, Kijlstra A, de Smet MD.
    Br J Ophthalmol; 1999 Oct 26; 83(10):1186-9. PubMed ID: 10502584
    [Abstract] [Full Text] [Related]

  • 32. [Advances in the diagnosis and treatment of infections caused by herpesvirus and JC virus].
    Arribas JR, Arrizabalaga J, Mallolas J, López-Cortés LF.
    Enferm Infecc Microbiol Clin; 1998 Oct 26; 16 Suppl 1():11-9. PubMed ID: 9859615
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Margolis TP.
    Surv Ophthalmol; 2000 Oct 26; 44(5):455. PubMed ID: 10809654
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
    Jabs DA, Bolton SG, Dunn JP, Palestine AG.
    Am J Ophthalmol; 1998 Dec 26; 126(6):817-22. PubMed ID: 9860006
    [Abstract] [Full Text] [Related]

  • 38. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.